Anti‐Ro/SSA autoantibody‐mediated regulation of extracellular matrix fibulins in human epithelial cells of the salivary gland

References

• Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H. M., Alexander E. L., Carsons S. E., et al. European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 2002; 61: 554–8
   PubMed Web of Science ®Google Scholar
• Pérez P., Goicovich E., Alliende C., Aguilera S., Leyton C., Molina C., et al. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 2000; 43: 2807–17
   PubMed Web of Science ®Google Scholar
• Santavirta N., Konttinen Y. T., Törnwall J., Segerberg M., Santavirta S., Matucci‐Cerinic M., et al. Neuropeptides of the autonomic nervous system in Sjögren's syndrome. Ann Rheum Dis 1997; 56: 737–40
   PubMed Web of Science ®Google Scholar
• Goicovich E., Molina C., Pérez P., Aguilera S., Fernández J., Olea N., et al. Enhanced degradation of proteins of the basal lamina and stroma by matrix metalloproteinases from the salivary glands of Sjögren's syndrome patients: correlation with reduced structural integrity of acini and ducts. Arthritis Rheum 2003; 48: 2573–84
   PubMed Web of Science ®Google Scholar
• Rosso F., Giordano A., Barbarisi M., Barbarisi A. From cell–ECM interactions to tissue engineering. J Cell Physiol 2004; 199: 174–80
   PubMed Web of Science ®Google Scholar
• Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161–74
   PubMed Web of Science ®Google Scholar
• Jackson C. J., Arkell J., Nguyen M. Rheumatoid synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP (TIMP1). Ann Rheum Dis 1998; 57: 158–61
   PubMed Web of Science ®Google Scholar
• Hagios C., Lochter A., Bissell M. J. Tissue architecture: the ultimate regulator of epithelial function?. Philos Trans R Soc Lond B Biol Sci 1998; 353: 857–70
   PubMed Web of Science ®Google Scholar
• Bissell M. J. Glandular structure and gene expression. Lessons from the mammary gland. Ann N Y Acad Sci 1998; 842: 1–6
   PubMed Web of Science ®Google Scholar
• Kabasakal Y., Kitapcioglu G., Turk T., Oder G., Durusoy R., Mete N., et al. The prevalence of Sjögren's syndrome in adult women. Scand J Rheumatol 2006; 35: 379–83
   PubMed Web of Science ®Google Scholar
• Frisch S. M., Screaton R. A. Anoikis mechanisms. Curr Opin Cell Biol 2001; 13: 555–62
   PubMed Web of Science ®Google Scholar
• Gilmore A. P. Anoikis. Cell Death Differ 2005; 12((Suppl 2))1473–7
   PubMed Web of Science ®Google Scholar
• Singh A. B., Sugimoto K., Harris R. C. Juxtacrine activation of epidermal growth factor (EGF) receptor by membrane‐anchored heparin‐binding EGF‐like growth factor protects epithelial cells from anoikis while maintaining an epithelial phenotype. J Biol Chem 2007; 282: 32890–901
   PubMed Web of Science ®Google Scholar
• Grossmann J. Molecular mechanisms of ‘detachment‐induced apoptosis –anoikis’. Apoptosis 2002; 7: 247–60
   PubMed Web of Science ®Google Scholar
• Argraves W. S., Greene L. M., Cooley M. A., Gallagher W. M. Fibulins: physiological and disease perspectives. EMBO Rep 2003; 4: 1127–31
   PubMed Web of Science ®Google Scholar
• Gallagher W. M., Argentini M., Sierra V., Bracco L., Debussche L., Conseiller E. MBP1: a novel mutant p53‐specific protein partner with oncogenic properties. Oncogene 1999; 18: 3608–16
   PubMed Web of Science ®Google Scholar
• Godyna S., Diaz‐Ricart M., Argraves W. S. Fibulin‐1 mediates platelet adhesion via a bridge of fibrinogen. Blood 1996; 88: 2569–77
   PubMed Web of Science ®Google Scholar
• Qing J., Maher V. M., Tran H., Argraves W. S., Dunstan R. W., McCormick J. J. Suppression of anchorage‐independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin‐1D in human fibrosarcoma‐derived cell lines. Oncogene 1997; 15: 2159–68
   PubMed Web of Science ®Google Scholar
• Hayashido Y., Lucas A., Rougeot C., Godyna S., Argraves W. S., Rochefort H. Estradiol and fibulin‐1 inhibit motility of human ovarian‐ and breast‐cancer cells induced by fibronectin. Int J Cancer 1998; 75: 654–8
   PubMed Web of Science ®Google Scholar
• Nakamura T., Ruiz‐Lozano P., Lindner V., Yabe D., Taniwaki M., Furukawa Y., et al. DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon‐injured arteries. J Biol Chem 1999; 274: 22476–83
   PubMed Web of Science ®Google Scholar
• Kowal R. C., Jolsin J. M., Olson E. N., Schultz R. A. Assignment of fibulin‐5 (FBLN5) to human chromosome 14q31 by in situ hybridization and radiation hybrid mapping. Cytogenet Cell Genet 1999; 87: 2–3
   PubMedGoogle Scholar
• Xiang Y., Sekine T., Nakamura H., Imajoh‐Ohmi S., Fukuda H., Yudoh K., et al. Fibulin‐4 is a target of autoimmunity predominantly in patients with osteoarthritis. J Immunol 2006; 176: 3196–204
   PubMed Web of Science ®Google Scholar
• Williamson M. R., Shuttleworth A., Canfield A. E., Black R. A., Kielty C. M. The role of endothelial cell attachment to elastic fibre molecules in the enhancement of monolayer formation and retention, and the inhibition of smooth muscle cell recruitment. Biomaterials 2007; 28: 5307–18
   PubMed Web of Science ®Google Scholar
• Zheng Q., Davis E. C., Richardson J. A., Starcher B. C., Li T., Gerard R. D., et al. Molecular analysis of fibulin‐5 function during de novo synthesis of elastic fibers. Mol Cell Biol 2007; 27: 1083–95
   PubMed Web of Science ®Google Scholar
• Pérez P., Goicovich E., Alliende C., Aguilera S., Leyton C., Molina C., et al. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 2000; 43: 2807–17
   PubMed Web of Science ®Google Scholar
• Schultz D. W., Klein M. L., Humpert A. J., Luzier C. W., Persun V., Schain M., et al. Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN‐1 is associated with age‐related macular degeneration in a large family. Hum Mol Genet 2003; 12: 3315–23
   PubMed Web of Science ®Google Scholar
• de Vega S., Iwamoto T., Nakamura T., Hozumi K., McKnight D. A., Fisher L. W., et al. TM14 is a new member of the fibulin family (fibulin‐7) that interacts with extracellular matrix molecules and is active for cell binding. J Biol Chem 2007; 28: 30878–88
   Web of Science ®Google Scholar
• Sisto M., Lisi S., Castellana D., Scagliusi P., D'Amore M., Caprio S., et al. Autoantibodies from Sjögren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A‐253. J Autoimmun 2006; 27: 38–49
   PubMed Web of Science ®Google Scholar
• Lisi S., Sisto M., Soleti R., Saponaro C., Scagliusi P., D'Amore M., et al. Fcgamma receptors mediate internalization of anti‐Ro and anti‐La autoantibodies from Sjögren's syndrome and apoptosis in human salivary gland cell line A‐253. J Oral Pathol Med 2007; 36: 511–23
   PubMed Web of Science ®Google Scholar
• Lisi S., D'Amore M., Lofrumento D., Mitolo V., Frassanito M. A., Dammacco F., et al. Modulation of the Fcgamma receptors induced by anti‐Ro and anti‐La autoantibodies: observations in salivary gland cells. Rheumatol Int 2008; 28: 943–48
   PubMed Web of Science ®Google Scholar
• Sens D. A., Hintz D. S., Rudisill M. T., Sens M. A., Spicer S. S. Explant culture of human submandibular gland epithelial cells: evidence for ductal origin. Lab Invest 1985; 52: 559–67
   PubMed Web of Science ®Google Scholar
• Kapsogeorgou E. K., Dimitriou I. D., Abu‐Helu R. F., Moutsopoulos H. M., Manoussakis M. N. Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren's syndrome: high expression of intercellular adhesion molecule‐1 (ICAM.1) in biopsy specimens and cultured cells. Clin Exp Immunol 2001; 124: 126–33
   PubMed Web of Science ®Google Scholar
• Kapsogeorgou E. K., Moutsopoulos H. M., Manoussakis M. N. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4. J Immunol 2001; 166: 3107–13
   PubMed Web of Science ®Google Scholar
• Wagenseil J. E., Mecham R. P. New insights into elastic fiber assembly. Birth Defects Res C Embryo Today 2007; 81: 229–40
   PubMedGoogle Scholar
• Kostka G., Giltay R., Bloch W., Addicks K., Timpl R., Fässler R., et al. Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin‐1‐deficient mice. Mol Cell Biol 2001; 21: 7025–34
   PubMed Web of Science ®Google Scholar
• Debeer P., Schoenmakers E. F., Twal W. O., Argraves W. S., De Smet L., Fryns J. P., et al. The fibulin‐1 gene (FBLN1) is disrupted in a t(12;22) associated with a complex type of synpolydactyly. J Med Genet 2002; 39: 98–104
   PubMed Web of Science ®Google Scholar
• Visconti R. P., Barth J. L., Keeley F. W., Little C. D. Codistribution analysis of elastin and related fibrillar proteins in early vertebrate development. Matrix Biol 2003; 22: 109–21
   PubMed Web of Science ®Google Scholar
• Weigell‐Weber M., Sarra G. M., Kotzot D., Sandkuijl L., Messmer E., Hergersberg M. Genomewide homozygosity mapping and molecular analysis of a candidate gene located on 22q13 (fibulin‐1) in a previously undescribed vitreoretinal dystrophy. Arch Ophthalmol 2003; 121: 1184–8
   PubMedGoogle Scholar
• Mullins R. F., Olvera M. A., Clark A. F., Stone E. M. Fibulin‐5 distribution in human eyes: relevance to age‐related macular degeneration. Exp Eye Res 2007; 84: 378–80
   PubMed Web of Science ®Google Scholar
• Loeys B., Van Maldergem L., Mortier G., Coucke P., Gerniers S., Naeyaert J. M., et al. Homozygosity for a missense mutation in fibulin‐5 (FBLN5) results in a severe form of cutis laxa. Hum Mol Genet 2002; 11: 2113–18
   PubMed Web of Science ®Google Scholar
• Qing J., Maher V. M., Tran H., Argraves W. S., Dunstan R. W., McCormick J. J. Suppression of anchorage‐independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin‐1D in human fibrosarcoma‐derived cell lines. Oncogene 1997; 15: 2159–68
   PubMed Web of Science ®Google Scholar
• Forti S., Scanlan M. J., Invernizzi A., Castiglioni F., Pupa S., Agresti R., et al. Identification of breast cancer‐restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serum. Breast Cancer Res Treat 2002; 73: 245–56
   PubMed Web of Science ®Google Scholar
• Greene L. M., Twal W. O., Duffy M. J., McDermott E. W., Hill A. D., O'Higgins N. J., et al. Elevated expression and altered processing of fibulin‐1 protein in human breast cancer. Br J Cancer 2003; 88: 871–8
   PubMed Web of Science ®Google Scholar
• Hayashi M., Merriam J. E., Klaver C. C., Zernant J., Bergen A. A., Smith R. T., et al. Evaluation of the ARMD1 locus on 1q25‐31 in patients with age‐related maculopathy: genetic variation in laminin genes and in exon 104 of HEMICENTIN‐1. Ophthalmic Genet 2004; 25: 111–19
   PubMedGoogle Scholar
• Xu X., Dong C., Vogel B. E. Hemicentins assemble on diverse epithelia in the mouse. J Histochem Cytochem 2007; 55: 119–26
   PubMed Web of Science ®Google Scholar
• Cho Y. G., Cho M. L., Min S. Y., Kim H. Y. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun Rev 2007; 7: 65–70
   PubMed Web of Science ®Google Scholar
• Pérez P., Kwon Y. J., Alliende C., Leyton L., Aguilera S., Molina C., et al. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios. Arthritis Rheum 2005; 52: 2751–60
   PubMed Web of Science ®Google Scholar
• Nelson C. M., Tien J. Microstructured extracellular matrices in tissue engineering and development. Curr Opin Biotechnol 2006; 17: 518–23
   PubMed Web of Science ®Google Scholar